INT37193

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.37
First Reported 1987
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 21
Total Number 21
Disease Relevance 15.06
Pain Relevance 3.12

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
joint 1
BDNF-AS (Homo sapiens)
Pain Link Frequency Relevance Heat
Arthritis 142 99.86 Very High Very High Very High
methadone 24 99.46 Very High Very High Very High
rheumatoid arthritis 284 99.32 Very High Very High Very High
Rheumatism 5 99.00 Very High Very High Very High
imagery 2 98.66 Very High Very High Very High
qutenza 10 98.56 Very High Very High Very High
corticosteroid 8 96.56 Very High Very High Very High
Inflammation 51 96.24 Very High Very High Very High
Infliximab 25 94.40 High High
cINOD 9 93.96 High High
Disease Link Frequency Relevance Heat
Hepatitis C Virus Infection 278 100.00 Very High Very High Very High
Hypersensitivity 2 100.00 Very High Very High Very High
Hepatitis 64 99.92 Very High Very High Very High
Arthritis 136 99.86 Very High Very High Very High
Renal Disease 114 99.52 Very High Very High Very High
Cancer 9 99.38 Very High Very High Very High
Rheumatoid Arthritis 284 99.32 Very High Very High Very High
Rheumatic Diseases 9 99.00 Very High Very High Very High
Allergic Dermatitis 2 99.00 Very High Very High Very High
Disease 228 98.32 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The flare component and the subjective itching sensation of the cutaneous allergy reaction to rat antigen in sensitized persons or anti-IgE in non-allergic persons were then markedly reduced.
Negative_regulation (reduced) of anti-IgE associated with allergic dermatitis, hypersensitivity and pruritus
1) Confidence 0.37 Published 1987 Journal Allergy Section Abstract Doc Link 3494409 Disease Relevance 0.70 Pain Relevance 0.71
Persistence of passive anti-D in maternal circulation after injection lasts several weeks or months and could have various consequences.
Negative_regulation (Persistence) of anti-D
2) Confidence 0.19 Published 2006 Journal J Gynecol Obstet Biol Reprod (Paris) Section Abstract Doc Link 16495836 Disease Relevance 0.51 Pain Relevance 0.14
Anti-MCV levels would have to decrease by 800 U/ml to account for such a reduction in DAS28 score.
Negative_regulation (decrease) of Anti-MCV
3) Confidence 0.08 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2374444 Disease Relevance 0.44 Pain Relevance 0.13
This implies that a large decline in anti-MCV level is needed to yield a substantial decrease in DAS28.
Negative_regulation (decline) of anti-MCV
4) Confidence 0.08 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2374444 Disease Relevance 0.44 Pain Relevance 0.18
Both DAS28 and anti-MCV levels decreased significantly during 2 years of follow up.
Negative_regulation (decreased) of anti-MCV
5) Confidence 0.06 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2374444 Disease Relevance 0.79 Pain Relevance 0.23
Of the 162 patients in our cohort, 76 (73 patients with RA and three patients with UA) were positive for anti-MCV at baseline.
Negative_regulation (positive) of anti-MCV associated with rheumatoid arthritis and arthritis
6) Confidence 0.06 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2374444 Disease Relevance 0.52 Pain Relevance 0.21
The latter reported a reduction in anti-HCV prevalence after 1991 (when both needles and syringes were available) compared to 1988–1990 (when needles but not syringes were available) compared to before needle and syringe exchange in 1987.
Negative_regulation (reduction) of anti-HCV associated with hepatitis c virus infection
7) Confidence 0.05 Published 2006 Journal Harm Reduct J Section Body Doc Link PMC1569828 Disease Relevance 0.73 Pain Relevance 0
Additionally, only one study [44] reported the mean methadone doses that may affect the reduction in anti-HCV incidence.
Negative_regulation (reduction) of anti-HCV associated with methadone and hepatitis c virus infection
8) Confidence 0.05 Published 2006 Journal Harm Reduct J Section Body Doc Link PMC1569828 Disease Relevance 0.64 Pain Relevance 0.18
Such findings are confirmed by an Australian prevalence study showing a reduction in anti-HCV incidence from 63% in 1995 to 51% in 1996 to 50% in 1997 [33], a Swedish cohort study [34] and a Swiss longitudinal and cross-sectional survey (including serological testing) [35,36].
Negative_regulation (reduction) of anti-HCV associated with hepatitis c virus infection
9) Confidence 0.05 Published 2006 Journal Harm Reduct J Section Body Doc Link PMC1569828 Disease Relevance 0.61 Pain Relevance 0.03
Anti-hepatitis C (anti-HCV) was positive in one case (case 1), but HCV was not detected on polymerase chain reaction (PCR).
Negative_regulation (positive) of anti-HCV associated with hepatitis c virus infection and hepatitis
10) Confidence 0.03 Published 2007 Journal Environ Health Perspect Section Body Doc Link PMC1797842 Disease Relevance 1.30 Pain Relevance 0.03
The serum anti-H. pylori IgG titer decreased to less than 75% of the baseline level by 24 weeks after completion of the eradication therapy.
Negative_regulation (decreased) of anti-H
11) Confidence 0.02 Published 2005 Journal Hepatogastroenterology Section Abstract Doc Link 15782980 Disease Relevance 0.62 Pain Relevance 0.08
Moreover, an anti-MCV decrease was significantly associated with DAS28 (disease activity score using 28 joint counts) improvements 12 months into therapy.


Negative_regulation (decrease) of anti-MCV in joint associated with disease
12) Confidence 0.01 Published 2008 Journal Arthritis Res Ther Section Abstract Doc Link PMC2656247 Disease Relevance 0.77 Pain Relevance 0.37
At the cutoff of 19.0 U/ml, both tests had an identical sensitivity, but the specificity of the anti-MCV was reduced.
Negative_regulation (reduced) of anti-MCV
13) Confidence 0.01 Published 2006 Journal Arthritis Res Ther Section Body Doc Link PMC1779400 Disease Relevance 0.78 Pain Relevance 0.28
The high negative predictive value of anti-C1q for severe renal disease may be helpful for prognostic stratification of SLE patients.
Negative_regulation (value) of anti-C1q associated with renal disease and systemic lupus erythematosus
14) Confidence 0.01 Published 2010 Journal Journal of Biomedicine and Biotechnology Section Body Doc Link PMC2857808 Disease Relevance 0.87 Pain Relevance 0
Nevertheless, among the patients with central NPSLE who tested positive at baseline, a decrease in the levels of anti-dsDNA, anti-ribosomal P, and anti-NMDAR antibodies was observed.
Negative_regulation (decrease) of anti-dsDNA
15) Confidence 0.00 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2556096 Disease Relevance 0.74 Pain Relevance 0.20
Among the patients with central NPSLE who tested positive at baseline, a decrease in the levels of anti-dsDNA, anti-ribosomal P, and anti-NMDAR antibodies was observed in 14 out of 17, 9 out of 10, and 7 out of 9 patients, respectively.
Negative_regulation (decrease) of anti-dsDNA
16) Confidence 0.00 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2556096 Disease Relevance 0.56 Pain Relevance 0
A decrease in the levels of anti-dsDNA, anti-ribosomal P, anti-cardiolipin, anti-?
Negative_regulation (decrease) of anti-dsDNA
17) Confidence 0.00 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2556096 Disease Relevance 0.77 Pain Relevance 0
Extensive imaging studies showed no evidence of tumor, but the patient was found to have positive anti-Yo antibodies and elevated cancer antigen 125 (CA-125).
Negative_regulation (have) of anti-Yo associated with cancer and imagery
18) Confidence 0.00 Published 2000 Journal Arch Phys Med Rehabil Section Abstract Doc Link 10857534 Disease Relevance 1.62 Pain Relevance 0.27
The prevalence of anti-AnnV, anti-PT, anti-Cprot and anti-Sprot was 19%, 10.4%, 4.4% and 8.1%, respectively.
Negative_regulation (prevalence) of anti-AnnV
19) Confidence 0.00 Published 2008 Journal Immunol. Invest. Section Abstract Doc Link 18569076 Disease Relevance 0.41 Pain Relevance 0.09
Six months later the prevalence of most antibodies in CSF did not change, however the levels of anti-dsDNA, anti-ribosomal P, and anti-NMDAR decreased.


Negative_regulation (decreased) of anti-dsDNA
20) Confidence 0.00 Published 2008 Journal PLoS ONE Section Abstract Doc Link PMC2556096 Disease Relevance 0.83 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox